StoneX Group’s Nautilus Biotechnolgy NAUT Stock Holding History

StoneX Group’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$10.1K	Buy	+10,319	New	+$12.3K	﹤0.01%	1848

Other funds holding NAUT

Sentinel Trust Houston, Texas $1.19B AUM 19.38% 1-Year Est. Return

Hillman Company Pittsburgh, Pennsylvania $261M AUM 2.04% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 32.98% 1-Year Est. Return

Ashton Thomas Private Wealth Scottsdale, Arizona $4.98B AUM 21.09% 1-Year Est. Return

Badgley Phelps Wealth Managers Seattle, Washington $5.8B AUM 25.34% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return

Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return

Apollon Wealth Management Mount Pleasant, South Carolina $8.72B AUM 23.07% 1-Year Est. Return

StoneX Group's NAUT Position: Q3 2026 in Review

StoneX Group opened a new position in Nautilus Biotechnolgy (NAUT) in Q3 2026: 10,319 shares worth $10.1K. The stake represents ﹤0.01% of the portfolio and ranks #1848 among its holdings.

21 funds tracked by Wall St. Rank hold NAUT as of Q3 2026.

StoneX Group held 10,319 shares of Nautilus Biotechnolgy worth $10.1K as of Q3 2026.
Nautilus Biotechnolgy was a new StoneX Group position in Q3 2026.
Nautilus Biotechnolgy made up ﹤0.01% of StoneX Group's portfolio in Q3 2026, its #1848 holding.
21 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q3 2026.

Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.